ArticleJournal of robotic surgery2026
Short-term outcomes of robotic-assisted versus open Frey procedure in chronic pancreatitis: a single-center retrospective cohort study.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Early surgery is increasingly recommended for chronic pancreatitis (CP) who meet surgical criteria. The Frey procedure is widely performed, but evidence regarding robotic Frey (R-Frey) remains limited due to the technical challenges posed by pancreatic inflammation and adhesions. This retrospective study included consecutive CP patients who underwent Frey surgery at a single center between January 2016 and May 2025. Primary outcomes were postoperative major complications (PMC; Clavien-Dindo ≥IIIa) and short-term pain relief. A 1:1 propensity score matching (PSM) was performed to reduce baseline imbalance. Among 81 patients included (34 R-Frey, 47 O-Frey), PSM yielded 25 matched pairs. In the overall cohort, no significant differences were observed in PMC (P = 0.270), or the proportion of patients achieving ≥ 50% VAS reduction (P = 0.647). R-Frey was associated with longer operative time (P = 0.013), shorter hospital stay (P = 0.035) and lower ICU stay rate (P = 0.050). After PSM, differences in hospital stay (P = 0.520) and ICU stay (P = 0.185) were no longer significant, while no significant differences were observed in complication rates or pain relief. R-Frey was performed in a selected cohort with more favorable baseline characteristics. After PSM, no significant differences in safety outcomes were detected, although the study was underpowered to establish non-inferiority. The initially observed advantages in hospital stay and ICU stay disappeared after matching, suggesting that they may influenced by patient selection rather than the surgical approach. These findings suggest that R-Frey is partly feasible in carefully selected CP patients, though larger studies are needed to confirm safety equivalence.
Indexed as
Identifiers
42635867What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.